Neuraxis NRXS
NYSE NRXS
$6.15 -0.12 (-1.91%)
At close: Aug 21, 2026 · 4:00 PM EDT

Neuraxis (NRXS) Return on Sales (2022 - 2025)

Neuraxis (NRXS) posted Return on Sales of 0.02% for Q4 2025, up 33.75% sequentially from 0.03% in Q3 2025, and little changed YoY from 0.02% in Q4 2024.

Neuraxis (NRXS) Return on Sales (2022 - 2025) Analysis & Trends

Neuraxis has reported Return on Sales for 4 years, with the latest figure at 0.02% in Q4 2025.

  • Quarterly Return on Sales changed 0.0% year-over-year to 0.02% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.02% (up 1.0% YoY) and the FY2025 annual result came in at 0.02%, up 1.0% from the prior year.
  • Return on Sales climbed to 0.02% in Q4 2025 per NRXS's latest filing, from 0.03% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.01% in Q2 2022 and troughed at 0.07% in Q3 2023.
  • A 4-year average of 0.03% and a median of 0.02% in 2025 frame the typical range for Return on Sales.
  • The sharpest annual moves came in 2023 and 2024: Return on Sales decreased 4 bps in 2023, then grew 4 bps in 2024.
  • Over 4 years, Return on Sales stood at 0.02% in 2022, then sank by 82 bps to 0.03% in 2023, then soared by 43 bps to 0.02% in 2024, then grew by 0 bps to 0.02% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods registered 0.02%, 0.03%, and 0.02% for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 0.00%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 0.00%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 0.00%
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -0.05%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 0.00%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 0.00%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 0.00%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 0.00%
9 Royalty Pharma 27.27 Bn 26.43 Bn - 0.00%
10 Neuraxis 74.54 Mn 66.21 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -0.02%
Sep 30, 2025 -0.03%
Jun 30, 2025 -0.02%
Mar 31, 2025 -0.03%
Dec 31, 2024 -0.02%
Sep 30, 2024 -0.03%
Jun 30, 2024 -0.05%
Mar 31, 2024 -0.03%
Dec 31, 2023 -0.03%
Sep 30, 2023 -0.07%
Jun 30, 2023 -0.02%
Mar 31, 2023 -0.01%
Dec 31, 2022 -0.02%
Sep 30, 2022 -0.02%
Jun 30, 2022 -0.01%